Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
Pharmacokinetics of ixazomib, an oral proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairment. [electronic resource] by
- Gupta, Neeraj
- Hanley, Michael J
- Venkatakrishnan, Karthik
- Perez, Raymond
- Norris, Robin E
- Nemunaitis, John
- Yang, Huyuan
- Qian, Mark G
- Falchook, Gerald
- Labotka, Richard
- Fu, Siqing
Producer: 20171113
In:
British journal of clinical pharmacology vol. 82
Availability: No items available.
|
|
13.
|
|
|
14.
|
All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma. [electronic resource] by
- Dimopoulos, Meletios A
- Grosicki, Sebastian
- Jędrzejczak, Wiesław W
- Nahi, Hareth
- Gruber, Astrid
- Hansson, Markus
- Gupta, Neeraj
- Byrne, Catriona
- Labotka, Richard
- Teng, Zhaoyang
- Yang, Huyuan
- Grzasko, Norbert
- Kumar, Shaji
Producer: 20200504
In:
European journal of cancer (Oxford, England : 1990) vol. 106
Availability: No items available.
|
|
15.
|
Model-Informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor. [electronic resource] by
- Gupta, Neeraj
- Hanley, Michael J
- Diderichsen, Paul M
- Yang, Huyuan
- Ke, Alice
- Teng, Zhaoyang
- Labotka, Richard
- Berg, Deborah
- Patel, Chirag
- Liu, Guohui
- van de Velde, Helgi
- Venkatakrishnan, Karthik
Producer: 20191113
In:
Clinical pharmacology and therapeutics vol. 105
Availability: No items available.
|
|
16.
|
Phase 2 study of all-oral ixazomib, cyclophosphamide and low-dose dexamethasone for relapsed/refractory multiple myeloma. [electronic resource] by
- Kumar, Shaji K
- Grzasko, Norbert
- Delimpasi, Sosana
- Jedrzejczak, Wieslaw W
- Grosicki, Sebastian
- Kyrtsonis, Marie-Christine
- Spencer, Andrew
- Gupta, Neeraj
- Teng, Zhaoyang
- Byrne, Catriona
- Labotka, Richard
- Dimopoulos, Meletios A
Producer: 20191227
In:
British journal of haematology vol. 184
Availability: No items available.
|
|
17.
|
A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease. [electronic resource] by
- Kutlar, Abdullah
- Ataga, Kenneth
- Reid, Marvin
- Vichinsky, Elliott P
- Neumayr, Lynne
- Blair-Britt, Loray
- Labotka, Richard
- Glass, Jonathan
- Keefer, Jeffrey R
- Wargin, William A
- Berenson, Ronald
- Perrine, Susan P
Producer: 20130103
In:
American journal of hematology vol. 87
Availability: No items available.
|
|
18.
|
Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myeloma. [electronic resource] by
- Goldschmidt, Hartmut
- Dimopoulos, Meletios A
- Rajkumar, S Vincent
- Weisel, Katja C
- Moreau, Philippe
- Chng, Wee-Joo
- Mikala, Gábor
- Cavo, Michele
- Ramasamy, Karthik
- Suryanarayan, Kaveri
- Teng, Zhaoyang
- Labotka, Richard
- Mateos, Maria Victoria
Producer: 20201130
In:
Leukemia vol. 34
Availability: No items available.
|
|
19.
|
Evaluation of the SCKnowIQ tool and reproductive CHOICES intervention among young adults with sickle cell disease or sickle cell trait. [electronic resource] by
- Gallo, Agatha M
- Wilkie, Diana J
- Wang, Edward
- Labotka, Richard J
- Molokie, Robert E
- Stahl, Christiane
- Hershberger, Patricia E
- Zhao, Zhongsheng
- Suarez, Marie L
- Johnson, Bonnye
- Pullum, Cherese
- Angulo, Rigoberto
- Thompson, Alexis
Producer: 20151005
In:
Clinical nursing research vol. 23
Availability: No items available.
|
|
20.
|
Ixazomib maintenance therapy in newly diagnosed multiple myeloma: An integrated analysis of four phase I/II studies. [electronic resource] by
- Dimopoulos, Meletios A
- Laubach, Jacob P
- Echeveste Gutierrez, Maria Asunción
- Grzasko, Norbert
- Hofmeister, Craig C
- San-Miguel, Jesus F
- Kumar, Shaji
- Labotka, Richard
- Lu, Vickie
- Berg, Deborah
- Byrne, Catriona
- Teng, Zhaoyang
- Liu, Guohui
- van de Velde, Helgi
- Richardson, Paul G
Producer: 20191115
In:
European journal of haematology vol. 102
Availability: No items available.
|